{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:03:48Z","timestamp":1792789428257,"version":"4.5.0"},"reference-count":36,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science of the Republic of Serbia","award":["41023\/2011"],"award-info":[{"award-number":["41023\/2011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: This study aimed to investigate oncologic and obstetrical outcomes of patients conservatively treated for atypical hyperplasia (AH), endometrial intraepithelial neoplasm (EIN), and early endometrial cancer (EC), as well as factors that influence these outcomes. Methods: This study included 87 women conservatively treated due to AH\/EIN and well-differentiated endometrioid EC confined only to the endometrium during past 10 years. Therapy type, course, and duration were registered. The response totherapy after 12 months (remission vs. disease persisting or progressing) was considered as the oncologic outcome. All attempted and achieved pregnancies, along with conception method, gestational week, and delivery type, were recorded. The obstetrical outcomes were classified as adverse (miscarriage) or successful (healthy child). Results: All patients received LNG-IUD along with GnRHa and, if indicated, metformin. Complete remission was achieved in 74.7% of patients. The disease was persisting in 17.2% and progressing in 3.5% of patients, while recurrence was registered in 4.6% of patients. Radical surgery during follow-up was indicated in 15% of patients due to condition deterioration. Pregnancy was attempted by 29.9% of patients, out of which nine succeeded (34.6%). There were two early miscarriages, while the remaining seven pregnancies ended in a term delivery of a healthy child, mostly by planned cesarean section. The only predictor of long-term disease remission was malignancy-free control histological findings. Better therapy response and achieving remission in shorter time were predictors of good obstetrical outcome. Conclusions: This study proved the efficacy and safety of current protocols for AH\/EIN\/EC conservative treatment and indicated that adequate early (6-month) response totherapy has the most importance for long-term remission and pregnancy achievement.<\/jats:p>","DOI":"10.3390\/diagnostics15111388","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:07:58Z","timestamp":1748592478000},"page":"1388","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Decade of Experience in Diagnostic and Conservative Treatment of Endometrial Malignancy\u2014Oncologic and Obstetrical Outcomes from a Referral Oncofertility Center"],"prefix":"10.3390","volume":"15","author":[{"given":"Katarina","family":"Stefanovic","sequence":"first","affiliation":[{"name":"Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Dr Koste Todorovica 26, 11000 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-9561","authenticated-orcid":false,"given":"Jelena","family":"Dotlic","sequence":"additional","affiliation":[{"name":"Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Dr Koste Todorovica 26, 11000 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Pilic","sequence":"additional","affiliation":[{"name":"Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Dr Koste Todorovica 26, 11000 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"Milosevic","sequence":"additional","affiliation":[{"name":"Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Dr Koste Todorovica 26, 11000 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-483X","authenticated-orcid":false,"given":"Olga","family":"Mihaljevic","sequence":"additional","affiliation":[{"name":"Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Dr Koste Todorovica 26, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-8975","authenticated-orcid":false,"given":"Aleksandra","family":"Beleslin","sequence":"additional","affiliation":[{"name":"Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Dr Koste Todorovica 26, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Stefanovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Dr Koste Todorovica 26, 11000 Belgrade, Serbia"},{"name":"Medical Faculty, University of Belgrade, Dr Subotica 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Uccella, S., Zorzato, P.C., Dababou, S., Bosco, M., Torella, M., Braga, A., Frigerio, M., Gardella, B., Cianci, S., and Lagana, A.S. (2022). Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women. Medicina, 58.","DOI":"10.3390\/medicina58091256"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siege","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000349891","article-title":"Controversies of the hormonal conservative treatment of endometrial cancer","volume":"75","author":"Minig","year":"2013","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Markowska, A., Chudecka-Glaz, A., Pitynski, K., Baranowski, W., Markowska, J., and Sawicki, W. (2022). Endometrial Cancer Managementin Young Women. Cancers, 14.","DOI":"10.3390\/cancers14081922"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gallo, A., Catena, U., Saccone, G., and Di Spiezio Sardo, A. (2021). Conservative Surgery in EndometrialCancer. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010183"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40477-022-00732-w","article-title":"Additional value of Doppler ultrasound to B-mode ultrasound in assessing for uterine intracavitary pathologies among perimenopausal and postmenopausal bleeding women: A multicentre prospective observational study in Vietnam","volume":"26","author":"Nguyen","year":"2023","journal-title":"J. Ultrasound."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5468\/ogs.22053","article-title":"Endometrial thickness and uterine artery Doppler parameters as soft markers for prediction of endometrial cancer in postmenopausal bleeding women: A cross-sectional study at tertiary referral hospitals from Vietnam","volume":"65","author":"Nguyen","year":"2022","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2294329","DOI":"10.1080\/01443615.2023.2294329","article-title":"The oncological and reproductive outcomes of fertility-preserving treatments for stage 1 grade 1 endometrial carcinoma: A systematic review and meta-analysis","volume":"44","author":"Ogunbiyi","year":"2024","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s10815-022-02475-3","article-title":"Analysis of IVF\/ICSI outcomes in infertile women with early-stage endometrial cancer and atypical endometrial hyperplasia after conservative treatment","volume":"39","author":"Guo","year":"2022","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ijgc-2018-000036","article-title":"Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer","volume":"29","author":"Chae","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.semdp.2021.12.001","article-title":"Histopathologic diagnosis of endometrial precancers: Updates and future directions","volume":"39","author":"Chen","year":"2022","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tjog.2018.11.017","article-title":"Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy","volume":"58","author":"Yang","year":"2019","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0000000000000493","article-title":"European Society of Gynecological Oncology Task Force for Fertility Preservation: Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients","volume":"25","author":"Rodolakis","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Falcone, F., Laurelli, G., Losito, S., Di Napoli, M., Granata, V., and Greggi, S. (2017). Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J. Gynecol. Oncol., 28.","DOI":"10.3802\/jgo.2017.28.e2"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Casadio, P., La Rosa, M., Alletto, A., Magnarelli, G., Arena, A., Fontana, E., Fabbri, M., Giovannico, K., Virgilio, A., and Raimondo, D. (2020). Fertility Sparing Treatment of Endometrial Cancer with and Without Initial Infiltration of Myometrium: A Single Center Experience. Cancers, 12.","DOI":"10.3390\/cancers12123571"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rodolakis, A., Scambia, G., Planchamp, F., Acien, M., Di Spiezio Sardo, A., Farrugia, M., Grynberg, M., Pakiz, M., Pavlakis, K., and Vermeulen, N. (2023). ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Hum. Reprod. Open, 2023.","DOI":"10.1093\/hropen\/hoac057"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ijgc-2020-001328","article-title":"Fertility preservation in women with early-stage gynecologic cancer: Optimizing oncologic and reproductive outcomes","volume":"31","author":"Floyd","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejogrb.2021.06.007","article-title":"The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: Case series of 30 patients and systematic review","volume":"263","author":"Piatek","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Emons, G., and Grundker, C. (2021). The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer. Cells, 10.","DOI":"10.3390\/cells10020292"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s13063-024-08414-0","article-title":"GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: A multicenter, open-label, randomized designed clinical trial protocol","volume":"25","author":"Liu","year":"2024","journal-title":"Trials"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s10815-024-03172-z","article-title":"A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia","volume":"41","author":"Goh","year":"2024","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cct.2014.06.014","article-title":"Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device\u00b1metformin\u00b1weight loss in endometrial cancer (feMME) trial","volume":"39","author":"Hawkes","year":"2014","journal-title":"Contemp. Clin. Trials"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: A systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/IGC.0000000000000098","article-title":"Fertility-preserving treatment in young women with endometrial adenocarcinoma: Along-term cohort study","volume":"24","author":"Wang","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jmig.2017.07.022","article-title":"Updates on Conservative Management of Endometrial Cancer","volume":"25","author":"Corzo","year":"2018","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: A systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2024.02.002","article-title":"2023 FIGO staging system for endometrial cancer: The evolution of the revolution","volume":"184","author":"Gaffney","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Giampaolino, P., Cafasso, V., Boccia, D., Ascione, M., Mercorio, A., Viciglione, F., Palumbo, M., Serafino, P., Buonfantino, C., and De Angelis, M.C. (2022). Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review. BioMed Res. Int., 2022.","DOI":"10.1155\/2022\/4070368"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/mco.2023.2651","article-title":"Conservative treatment of endometrial cancer in women of reproductive age (Review)","volume":"19","author":"Bourou","year":"2023","journal-title":"Mol. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gullo, G., Cucinella, G., Chiantera, V., Dellino, M., Cascardi, E., Torok, P., Herman, T., Garzon, S., Uccella, S., and Lagana, A.S. (2023). Fertility-Sparing Strategies for Early-Stage Endometrial Cancer: Stepping towards Precision Medicine Based on the Molecular Finger print. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010811"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mutlu, L., Manavella, D.D., Gullo, G., McNamara, B., Santin, A.D., and Patrizio, P. (2022). Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes. Cancers, 14.","DOI":"10.3390\/cancers14215187"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Etrusco, A., Lagana, A.S., Chiantera, V., Mikus, M., Arsalan, H.M., d\u2019Amati, A., Vitagliano, A., Cicinelli, E., Favilli, A., and D\u2019Amato, A. (2024). Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A Systematic Review. Biomolecules, 14.","DOI":"10.3390\/biom14030306"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Contreras, N.A., Sabadell, J., Verdaguer, P., Julia, C., and Fernandez-Montoli, M.E. (2022). Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052531"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijgo.70059","article-title":"A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia","volume":"169","author":"Catena","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/11\/1388\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:43:56Z","timestamp":1760031836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/11\/1388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["diagnostics15111388"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15111388","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}